Novel antisense therapy targets α-synuclein pathologies in neurodegenerative diseases

  • Post author:
  • Post category:uncategorized

TMDU researchers demonstrate proof of concept of antisense nucleic acid therapy to prevent the spread of α-synuclein pathologies in synucleinopathies.